Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections (PROTRACT)

January 13, 2025 updated by: DienstThoracaleEnVasculaireHeelkunde, University Hospital, Ghent

Reasons for Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections

In this study, the reasons for prolonged hospital stay after thoracoscopic (video- or robot-assisted) anatomical lung resections are investigated. Currently, whenever possible, these anatomical lung resections are performed thoracoscopically, as they offer significant improvements in terms of postoperative pain, number of postoperative complications, rehabilitation, tolerance for adjuvant chemotherapy, and length of hospital stay. The development of an 'Enhanced Recovery After Surgery' (ERAS) protocol for lung surgery has further reduced hospital stay and the need for opioids for analgesia. Despite the optimal implementation of the ERAS protocol, there are still patients who need to stay in the hospital longer than the median. The aim of this research is to investigate the reasons for this.

Study Overview

Study Type

Observational

Enrollment (Estimated)

140

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Bruges, Belgium
        • Recruiting
        • AZ Sint-Jan Brugge-Oostende AV
        • Contact:
        • Contact:
          • Jan Lesaffer, MD
      • Ghent, Belgium
        • Recruiting
        • Ghent University Hospital
        • Contact:
        • Contact:
        • Contact:
          • Lauren Villeirs, MD
        • Contact:
          • Liesbeth Desender, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients scheduled for thoracoscopic anatomical lung resection. An estimated 136 patients should be included after power calculation

Description

Inclusion Criteria:

  • Patients referred for elective minimally invasive (uniportal or multiportal video- or robot-assisted) anatomical lung resection (lobectomy or segmentectomy)
  • Informed consent obtained pre-operatively
  • Age 18 years or older

Exclusion Criteria:

  • Patients younger than 18 years old
  • Traumatic event as indication for lung resection
  • Non-anatomical lung resections
  • Thoracotomy
  • Patients already hospitalized for other pathologies, pre-existent and not related to the lung surgery
  • Urgent/emergency procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients undergoing a minimally invasive anatomical lung resection
Patients undergoing a minimally invasive anatomical lung resection, receiving perioperative care according to the ERAS protocol for Lung Surgery
Perioperative care according to the ERAS protocol for lung surgery
Other Names:
  • VATS lobectomy
  • RATS lobectomy
  • VATS segmentectomy
  • RATS segmentectomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of hospital stay (days)
Time Frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months
The primary objective is to investigate the length of hospital stay of patients undergoing minimally invasive thoracoscopic anatomical lung resection with peri-operative care according to the Enhanced Recovery After Surgery (ERAS) protocol for lung surgery
immediately after surgery until hospital discharge (1 week on average), up to 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reasons for delayed discharge (more than 2 days postoperatively) identified through daily questionnaires and review of medical records.
Time Frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months
  • Postoperative pain (NRS)
  • Postoperative nausea and vomiting (yes/no)
  • Air leak duration (days)
immediately after surgery until hospital discharge (1 week on average), up to 3 months
Number, frequency and severity of postoperative complications during hospital stay.
Time Frame: immediately after surgery until hospital discharge (1 week on average), up to 3 months
immediately after surgery until hospital discharge (1 week on average), up to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 12, 2024

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

October 1, 2024

First Submitted That Met QC Criteria

October 10, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 13, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • THE-2024-0246

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Lobectomy

Clinical Trials on VATS/RATS anatomical lung resection

Subscribe